France chooses companies to supply free medical cannabis for trial program

France chooses companies to supply free medical cannabis for trial program
Published
January 25, 2021
| By
Alfredo Pascual
The French Agency for the Safety of Medicines and Health Products (ANSM) selected the companies that will supply France’s medical cannabis pilot program that’s intended to provide free products to patients enrolled in the trial.
Cannabis companies from Australia, Canada, Israel and the United Kingdom – in partnership with French pharmaceutical distributors – will provide the products for up to 3,000 patients and will not receive any money for supplying the medical cannabis.
French authorities selected main suppliers, as well as substitute suppliers to cover any shortfalls.

Related Keywords

Australia ,Canada ,United Kingdom ,Israel ,France ,French ,Intsel Chimos ,Medipha Sante ,Nicolas Authier ,Laboratoires Bouchara Recordati ,French Agency For The Safety Of Medicines ,U Emmac Life Sciences ,Emmac Life Sciences ,Health Products ,French Agency ,Little Green Pharma ,Aurora Cannabis ,Laboratoires Bouchara ,ஆஸ்திரேலியா ,கனடா ,ஒன்றுபட்டது கிஂக்டம் ,இஸ்ரேல் ,பிரான்ஸ் ,பிரஞ்சு ,நிக்கோலாஸ் ஔஉதிிஎற் ,ஆரோக்கியம் ப்ராடக்ட்ஸ் ,கொஞ்சம் பச்சை பார்மா ,அரோரா கஞ்சா ,